HealthEquity, Inc. $HQY Shares Sold by KBC Group NV

KBC Group NV decreased its position in HealthEquity, Inc. (NASDAQ:HQY) by 35.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,411 shares of the company’s stock after selling 1,341 shares during the period. KBC Group NV’s holdings in HealthEquity were worth $253,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in HQY. Farther Finance Advisors LLC boosted its holdings in HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $33,000. WPG Advisers LLC purchased a new stake in shares of HealthEquity in the first quarter valued at approximately $28,000. Cullen Frost Bankers Inc. grew its holdings in HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after acquiring an additional 224 shares during the period. Finally, Sellwood Investment Partners LLC purchased a new position in HealthEquity in the second quarter worth $58,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on HQY. Barrington Research restated an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. Wall Street Zen lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday. Jefferies Financial Group lifted their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. BMO Capital Markets initiated coverage on HealthEquity in a research note on Thursday, November 13th. They set a “market perform” rating and a $100.00 price target on the stock. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $119.00.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the completion of the transaction, the executive vice president directly owned 79,456 shares of the company’s stock, valued at $7,477,604.16. The trade was a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president directly owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 9,281 shares of company stock valued at $859,867. Insiders own 1.50% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY opened at $102.74 on Wednesday. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65. The stock has a market cap of $8.85 billion, a P/E ratio of 62.27, a PEG ratio of 1.36 and a beta of 0.47. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. The company has a 50-day moving average of $94.36 and a two-hundred day moving average of $96.24.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $325.80 million during the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.